FANCA and Friedreich ataxia: Although we initially focused our aims in the specific AAVS1 targeting of the FANCA gene, whose mutations account for about 60% of the FA patients (Casado et al, 2007), this approach could be easily applied to the delivery of all the other FANC genes.